Coya Therapeutics, Inc. (COYA)
5.01
+0.12
(+2.45%)
USD |
NASDAQ |
Sep 21, 16:00
5.01
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Profit Margin (Quarterly) : -2.72K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.72K% |
| March 31, 2026 | -2.87K% |
| December 31, 2025 | -144.2% |
| September 30, 2025 | -59.36% |
| June 30, 2025 | -3.73K% |
| March 31, 2025 | -2.83K% |
| Date | Value |
|---|---|
| December 31, 2024 | -145.8K% |
| September 30, 2024 | |
| June 30, 2024 | -84.42% |
| March 31, 2024 | -3.98K% |
| December 31, 2023 | 21.09% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.77% |
| Return on Assets | -50.16% |
| Return on Invested Capital | -56.77% |
| Gross Profit Margin (Quarterly) | 98.85% |
| Operating Margin (Quarterly) | -2.89K% |
| Return on Net Operating Assets | -631.2% |